Last update: Aug. 17, 2019
Minimal risk for breastfeeding and infant.
Arterial hypertension (AH) which is uncontrolled during pregnancy increases the incidence of prematurity and intrauterine malnutrition, which can lead to problems in the establishment of breastfeeding (Lawrence 2016 p.565).
There are no differences in the sodium and potassium content in the colostrum of mothers with AH and without AH (Sírio 2007).
Breastfeeding may be therapeutic for maternal AH. Prolactin is a relaxant for the mother and the breast is an organ of excretion that produces about a litre a day, so diuretics should be prescribed at a lower dose (Countouris 2016, Lawrence 2016 p.595).
A healthy diet, low in salt, and exercise are essential in the prevention and treatment of hypertension.
Pharmacological treatment of hypertension includes diuretics and antihypertensives.
Among diuretics, acetazolamide, chlorothiazide, hydrochlorothiazide, and spironolactone are minimally excreted in milk and are compatible with breastfeeding (Malachias 2016, Lawrence 2016 p.595).
In almost all therapeutic antihypertensive groups there is one or more which are considered compatible with breastfeeding: hydralazine and methyldopa; labetalol and propranolol; diltiazem, nifedipine and verapamil; captopril and enalapril are some of them (Anderson 2018, Malachias 2016).
Breastfeeding decreases maternal risk of developing hypertension and cardiovascular disease (Park 2018, Zhang 2015, Stuebe 2011, Schwarz 2009).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.